LOS ANGELES, Aug. 8, 2012 /PRNewswire/ -- geneME (www.geneme.me), the leading provider of whole food based personalized health, beauty and wellness products customized to your individual DNA, announced today that it has partnered with America's Health Coach, MD, Dr. Asa Andrew on the launch of one of the world's first and only customized DNA nutritional supplements. Dr. Asa, a national best-selling author, host of the nationally-syndicated primetime radio program, "Dr. Asa On Call", and founder of Diagnosis HOPE, a non-profit dedicated to health education and supporting the uninsured, will endorse geneME and its mission of serving the public with the highest standards in natural products and groundbreaking new research in the field of DNA and genetics.

geneME is the culmination of almost 20 years of research by a group of top physicians, scientists, and researchers who have harnessed the incredible breakthroughs in DNA research to create one of the first, and only, line of supplement products that are truly customized to the requirements of each individual's DNA.

"We are pleased to have someone of Dr. Asa's caliber on board the geneME team," said Dany Sfeir, Chief Marketing Officer with geneME. "Dr. Asa firmly believes, as we do, that the solution to the growing healthcare dilemma is not a one-size-fits-all solution but rather products and services that are truly customized to the requirements and needs of each individual's DNA. We look forward to a long and fruitful relationship with America's Health Coach, MD, Dr. Asa, by educating and sharing with the public the exciting breakthroughs in DNA research and testing."

"geneME is truly at the cutting-edge in terms of developing whole food based supplements tailored exclusively for a consumer's unique genetic makeup," said Dr. Asa Andrew. "I'm a firm believer in the vision and research of geneME and their mission to enable consumers to live longer, healthier, happier lives through personalized healthcare. This research is the future of nutrition and prevention."

America's Health Coach, MD, Dr. Asa, is a national best-selling author, lifestyle transformation expert, host of one of the fastest growing nationally-syndicated radio and television programsin America, "Dr. Asa On Call", and is a much-in-demand health contributor to FOX, ABC, NBC, CBS, and other media outlets. With his national best-selling book, newly-launching educational curriculum, upcoming television projects, still serving as CEO of his rapidly growing media companies, and dedicating considerable time to his non-profit organization, Diagnosis Hope, Dr. Asa is on a nationwide crusade to see people transform their lives to get well, stay well, and live well. Having moved away from clinical practice to focus on educational media, Dr. Asa is an active member of the American Academy of Nutrition and Dietetics, the American College of Preventative Medicine, The National Strength and Conditioning Association, and has served as an honorary chair to the American Diabetes Association.

About geneME

geneME (www.geneme.me) is the culmination of almost 20 years of research by a group of physicians, scientists, and researchers who have harnessed the incredible breakthroughs in DNA research to create the first, and only, line of products that are truly customized. geneME actually manufactures one-of-a-kind formulations to the requirements of each individual's DNA. For more information on geneME, visit http://www.geneme.me.

About America's Health Coach, MD, Dr. Asa Andrew

America's Health Coach, MD, Dr. Asa is a national best-selling author,host of one of the fastest growing nationally syndicated radio and television programsin America, "Dr. Asa On Call", and is a healthcontributor to FOX, ABC, NBC, CBS, and other media outlets. For more information on Dr. Asa Andrew, visit http://www.DrAsa.com or Twitter @DrAsa.

Read the original here:
geneME® teams with America's Health Coach, MD®, Dr. Asa Andrew, on one of the world's first and only customized DNA ...

A man convicted of killing his roommate with a ball bat requested that more of the DNA on the weapon be tested in hopes of exonerating himself, but a judge has denied him.

Kenneth Eugene Carter, 51, was charged with first-degree murder in the death of Ron Fortner, 51, and the malicious wounding of another Buehring Avenue roommate, Brady Dunlap, 61.

His first trial in March ended in a hung jury, but a second jury in May found him guilty.

He is serving a life sentence without a chance for parole.

On Tuesday, Kanawha Circuit Judge James Stucky denied Carter's motion to have 20 swabs taken by police from the ball bat tested for DNA. Prosecutors objected and said any information from further testing would be "confusing and not relevant."

Charles Hamilton, Carter's court-appointed public defense attorney, has appealed his murder conviction to the state Supreme Court. He claims the state was negligent when a lab tested only six of those 26 swabs.

Hamilton said, "We have this evidence that is sitting there at the State Police lab. I think it is

pretty obvious and significant that there could be another person's DNA and he's entitled to another testing."

Hamilton said he and co-counsel David Dawson originally believed that only six of the 26 samples were tested because the rest weren't viable. He said they discovered more recently that wasn't true.

"The idea of the perpetrator of the crime was a significant issue in this case," Hamilton said. "Who wielded that bat? Kenny Carter has maintained his innocence from day one."

Read the original:
DNA test denied for man convicted in fatal beating

Published: Aug. 7, 2012 at 5:36 PM

NEW YORK, Aug. 7 (UPI) -- North African Jews are more closely related to Jews from other parts of the world than to their non-Jewish neighbors in North Africa, a DNA study has found.

The study strengthens other research suggesting Jewish people from Europe and the Middle East share more DNA with one another than they do with outside groups, study author Harry Ostrer, a medical geneticist at the Albert Einstein College of Medicine in New York, said.

"Jews tend to be more related to one another than they are to non-Jews, including non-Jews living nearby -- it's true in every region," he told the Los Angeles Times.

DNA carries a record of Jewish migrations over the centuries, the study researchers said.

Some DNA traces back to the Middle Eastern peoples thought to have migrated to North Africa more than 2,000 years ago, while other DNA proves connections to Spanish and Portuguese Jews who fled to North Africa after their expulsion from the Iberian Peninsula in the late 15th century.

Ostrer and his colleagues analyzed DNA samples from 145 people of North African Jewish origin from Morocco, Algeria,Tunisia, Djerba (an island off the Tunisian coast) and Libya.

North African Jewish populations clearly had genetic patterns more similar to European and Middle Eastern Jews than non-Jewish people currently living in the region, the researchers said, suggesting that once established in their communities Jews in the region did not often intermarry with non-Jewish neighbors.

Go here to read the rest:
DNA traces historic Jewish migrations

STONY BROOK, NY--(Marketwire -08/07/12)- Applied DNA Sciences, Inc. (APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it has significantly expanded its office, production, and laboratory space and increased its personnel. The expansion reflects the company's continued worldwide growth in production capacity, technology advancement, and global customer support. Those factors are also seen in a steady rise in shipments of its DNA products, the core technology around which the company's authentication services are built.

The company's brick-and-mortar footprint has increased by well over 50% over the last year. The company has added nine positions in that time.

Dr. James A. Hayward, President and CEO of APDN, pointed out that the expansion has been driven in part by product shipments. "By the end of December, 2011, we recorded a substantial increase in our monthly shipments of DNA; as a result, our last two previously announced quarters were each record-setters. Incremental demand should be sustained as new opportunities are addressed."

Dr. Hayward concluded: "In addition to the current growth we are experiencing across the firm, our LMI-managed microchip project is leading the DOD's Defense Logistics Agency to seriously consider mandating SigNature DNA for microcircuits. We are confident we can support a DOD mandate and continue to source additional candidates as this effort might expand.

"In addition, the initial responses to our new product lines, smartDNA and digitalDNA, have been encouraging. Our management team felt it appropriate to grow our resources at this time."

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 8, 2011 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

More:
Applied DNA Sciences Expands Plant and Personnel